Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital, has received the 2024 Nobel Prize in Physiology or Medicine for the discovery of microRNAs, a class of tiny RNA molecules that regulate the activities of genes in plants and animals, including humans.

Gary B. Ruvkun, a professor of genetics at Harvard Medical School, was awarded the 2024 Nobel Prize in Medicine, the Nobel Committee announced early Monday morning.

A pair of Massachusetts professors won a Nobel Prize for discovering microRNA, which could lead to new ways of treating cancer.

In the late 1980s, Ambros and Ruvkun were postdoctoral researchers in the laboratory of Robert Horvitz, who received the Nobel Prize in 2002 with Sydney Brenner and John Sulston. In Horvitz's laboratory, they studied the relatively inconspicuous, 1-mm long roundworm C elegans.

The Nobel Assembly said that their discovery is "proving to be fundamentally important for how organisms develop and function."

Similar flexibility, though in an area with far more profound consequences than ethology, has been demonstrated with regard to this year’s physics prize. Showing a sense of timeliness not always apparent in its deliberations,

Two scientists won the Nobel Prize in physiology or medicine on Monday for their discovery of microRNA, tiny bits of genetic material that serve as on and off switches inside cells that help

Victor Ambros and Gary Ruvkun were awarded the Nobel Prize in Physiology or Medicine on Monday for the discovery of microRNA, a tiny class of RNA molecules that play a crucial role in determining how organisms mature and function — and how they sometimes malfunction.

The Nobel Prize in physiology or medicine was awarded to Massachusetts professors Victor Ambros and Gary Ruvkun for the discovery of microRNA.